𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Coexistent autoimmune autonomic ganglionopathy and myasthenia gravis associated with non–small-cell lung cancer

✍ Scribed by Amanda C. Peltier; Bonnie K. Black; Satish R. Raj; Peter Donofrio; David Robertson; Italo Biaggioni


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
273 KB
Volume
41
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We report the case of a 55‐year‐old man with non–small‐cell lung cancer who underwent radiation, chemotherapy with carbotaxol and paclitaxel, and left upper lobe removal 2 years prior to evaluation. He was referred for disabling orthostatic hypotension (113/69 mm Hg supine and 66/47 mm Hg standing after 10 minutes) without a compensatory heart rate increase (57 to 59 beats per minute), fatigue, and constipation with episodes of ileus. Clinical examination showed mild ptosis bilaterally, fatiguable neck flexor weakness, and hip flexor weakness. Blood pressure response to Valsalva maneuver was abnormal with an absence of phase 4 overshoot and a Valsalva heart rate ratio of 1.04. Plasma norepinephrine level was low (79 pg/ml supine, 330 pg/ml standing). Single‐fiber electromyography of the right extensor digitorum communis revealed normal mean consecutive difference (jitter) but several pairs exceeded a jitter of 100 μs. Antibodies against muscle acetylcholine receptor [(AChR) 0.66 nmol/L, normal <0.02 nmol/L] and ganglionic AChR (0.34 nmol/L, normal <0.02 nmol/L) were present. Treatment with plasma exchange normalized responses to standing posture (105/68 supine to 118/82 mm Hg standing, 66 to 79 beats per minute), to Valsalva (normal blood pressure overshoot, hazard ratio 1.47), norepinephrine (194 pg/ml supine, 763 pg/ml standing), and jitter measurements. We conclude that autoimmune autonomic ganglionopathy and myasthenia gravis can coexist and suggest that the latter should be excluded in patients with autoimmune autonomic ganglionopathy who complain of fatigue that shows improvement with non‐supine rest. Muscle Nerve, 2009


📜 SIMILAR VOLUMES


MicroRNA-328 is associated with (non-sma
✍ Shilpi Arora; Aarati R. Ranade; Nhan L. Tran; Sara Nasser; Shravan Sridhar; Rona 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 446 KB 👁 1 views

## Abstract Brain metastasis (BM) can affect ∼ 25% of nonsmall cell lung cancer (NSCLC) patients during their lifetime. Efforts to characterize patients that will develop BM have been disappointing. microRNAs (miRNAs) regulate the expression of target mRNAs. miRNAs play a role in regulating a varie

Reduced survival in patients with stage-
✍ Rafael Rosell; Alex Pifarré; Mariano Monzó; Julio Astudillo; M. Paz López-Cabrer 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 88 KB 👁 2 views

To better understand whether replication-error-type instability (RER 1 ) is a frequent genetic alteration event in surgicalpathologic stage-I non-small-cell lung cancer (NSCLC) and identify whether it constitutes an independent prognostic parameter, we examined 35 surgical-pathologic stage-I-NSCLC p

Induction of tubulin by docetaxel is ass
✍ Jinghua Tsai Chang; Gee-Chen Chang; Jiunn-Liang Ko; Hung-Ya Liao; Hsin-Ju Liu; C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 408 KB 👁 1 views

Docetaxel (DOC), a member of the taxane family of anticancer drugs, binds to tubulin and produces unnaturally stable microtubules that induce cell death. DOC is used clinically alone or in combination with other compounds to treat advanced stages of cancer. We have treated the human lung cancer cell

Host immune gene polymorphisms were asso
✍ Juncheng Dai; Zhibin Hu; Jing Dong; Lin Xu; Shiyang Pan; Yue Jiang; Guangfu Jin; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 313 KB 👁 2 views

## Abstract Laboratory‐based studies showed that host immune genes could influence the prognosis of non‐small‐cell lung cancer (NSCLC). Therefore, genetic polymorphisms in host immune genes may serve as predictors for NSCLC clinical outcome. To test the hypothesis that functional single nucleotide

Polymorphisms of the interleukin-1 β gen
✍ Shanbeh Zienolddiny; David Ryberg; Valentina Maggini; Vidar Skaug; Federico Canz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB 👁 1 views

## Abstract Lung cancer is one of the leading causes of cancer death worldwide. Tobacco smoking is the main risk factor for lung cancer. Less than 20% of smokers develop lung cancer in their lifetime, however, indicating individual variations in lung cancer risk. Pro‐inflammatory cytokines produced